Remove Clinical Research Remove Disease Remove Treatment
article thumbnail

CAR-T therapy could “alter the treatment paradigm” of multiple sclerosis

Drug Discovery World

KYV-101 is an autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate for use in B cell-driven autoimmune diseases. KYV-101, specifically targets CD19, a protein expressed on the surface of B cells, which is involved in various types of autoimmune diseases.

Therapies 312
article thumbnail

“Nothing scares us” – Ukraine’s clinical research sector begins fearless recovery

Drug Discovery World

Following the news that the number of clinical trial recruiting sites in Ukraine has dropped by half since the Russian invasion, DDW’s Diana Spencer examines clinical trial data from analytics company Phesi and speaks to Dr Olena Karpenko , Clinical Research Director at Medical Center Ok!Clinic+ Dr Olena Karpenko.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Current Clinical Research Trends in GLP-1 (Glucagon-Like Peptide 1) Treatment

Conversations in Drug Development Trends

The recent surge in GLP-1 treatments has ignited a profound shift in the pharmaceutical landscape, with more studies being announced than ever before. However, the treatment journey does not end with weight reduction, as maintaining weight loss overall is equally crucial.

article thumbnail

Beyond blood tests: The evolution of digital biomarkers in clinical research

Drug Discovery World

However, this robust system can become alarmingly vulnerable when confronted with debilitating conditions like Alzheimer’s, cancer, and cardiovascular diseases. They mark a significant shift in clinical research, utilising technology to capture real-time patient data. The potential of these digital tools is vast.

article thumbnail

Applying Artificial Intelligence to Transform the Patient Enrollment Paradigm in Clinical Research

PPD

The benefits of utilizing AI in clinical research Patient recruitment and diversity AI is increasingly being utilized in the recruitment process for clinical trials , aiming to connect individuals with potential benefits from investigational treatments.

article thumbnail

Looking for Opportunities to Accelerate Clinical Research in Rare Diseases

LifeSciVC

By Mike Cloonan, Chief Executive Officer of Sionna Therapeutics, as part of the From The Trenches feature of LifeSciVC The drug development process in rare diseases is rife with challenges especially when companies target significant differentiation or first-in-class targets.

article thumbnail

Michael J Fox Foundation awards $2 million to Parkinson’s apathy treatment

Drug Discovery World

The grant will be used to conduct a Phase I clinical study of IRL757, a drug candidate in development as a novel treatment of apathy. The grant was awarded under MJFF’s program ‘Parkinson’s Disease Therapeutics Pipeline Program.’ The MJFF is the world’s largest nonprofit funder of Parkinson’s research.

Treatment 147